A. Lodberg

Principles of the activin receptor signaling pathway and its inhibition.

A. Lodberg, 2021, Cytokine & growth factor reviews.

A soluble activin type IIA receptor mitigates the loss of femoral neck bone strength and cancellous bone mass in a mouse model of disuse osteopenia.

M. Eijken, B. V. D. van der Eerden, A. Lodberg, 2018, Bone.

Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice.

M. Eijken, B. V. D. van der Eerden, A. Lodberg, 2020, Bone.

A follistatin‐based molecule increases muscle and bone mass without affecting the red blood cell count in mice

M. Eijken, A. Lodberg, J. Thomsen, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin A

A. Lodberg, J. Thomsen, A. Brüel, 2020, MethodsX.

Immobilization induced osteopenia is strain specific in mice

C. Larsen, A. Lodberg, J. Thomsen, 2015, Bone reports.

Sex-Specific Effect of High-Fat Diet on Glycerol Metabolism in Murine Adipose Tissue and Liver

J. Lebeck, A. Lodberg, J. Thomsen, 2020, Frontiers in Endocrinology.

Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcoma

B. Fuchs, M. Eijken, O. Neklyudova, 2020, Cancer medicine.

Highly Responsive Bioassay for Quantification of Glucocorticoids.

A. Lodberg, Mathias Flensted Poulsen, M. Overgaard, 2024, Analytical chemistry.